American Heart Journal
Volume 158, Issue 4 , Page e59 , October 2009

Are we sure we have taken the best from clopidogrel?

References 

  1. Goy J, Urban P, Kaufmann U, et al. Incidence of stent thrombosis and adverse cardiac events 5 years after sirolimus stent implantation in clinical practice. Am Heart J. 2009;157:883–888
  2. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–678
  3. Serebruany VL, Steinhubl SR, Berger PB, et al. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol. 2005;45:246–251
  4. CAPRIE Steering Committee . A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329–1339
  5. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double blind, placebo-controlled trial. Lancet. 2004;364:331–337

PII: S0002-8703(09)00564-X

doi: 10.1016/j.ahj.2009.07.026

American Heart Journal
Volume 158, Issue 4 , Page e59 , October 2009

Article Tools